Julia Engelmann

Dr. Julia Engelmann

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2013 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MAMartin J. Aryee
Martin J. Aryee
WLWennuan Liu
Wennuan Liu
JEJulia Engelmann
Julia Engelmann
PNPhilipp Nuhn
Philipp Nuhn
MGMeltem Gurel
Meltem Gurel
SYSrinivasan Yegnasubramanian
Srinivasan Yegnasubramanian
Prostate tumors develop a unique epigenetic DNA methylation signature that is clonally maintained in disseminated metastases.

28 May 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MHMichael Hannus
Michael Hannus
MBMichaela Beitzinger
Michaela Beitzinger
JEJulia Engelmann
Julia Engelmann
MWMarie-Theresa Weickert
Marie-Theresa Weickert
RSRainer Spang
Rainer Spang
GMGunter Meister
Gunter Meister
Short interfering RNAs (siRNAs) are widely used as tool for gene inactivation in basic research and therapeutic applications. One of the major shortcomings of siRNA experiments are sequence-specific off-target effects. Such effects are largely unpredictable because siRNAs can affect partially complementary sequences and function like microRNAs (miRNAs), which inhibit gene expression on mRNA stability or translational levels. Here we demonstrate that novel, enzymatically generated siRNA pools—referred to as siPools—containing up to 60 accurately defined siRNAs eliminate off-target effects. This is achieved by the low concentration of each individual siRNA diluting sequence-specific off-target effects below detection limits. In fact, whole transcriptome analyses reveal that single siRNA transfections can severely affect global gene expression. However, when complex siRNA pools are transfected, almost no transcriptome alterations are observed. Taken together, we present enzymatically produced complex but accurately defined siRNA pools with potent on-target silencing but without detectable off-target effects.

16 August 2017 in The Plant Cell
Verified
Journal Article
Open access
PDF file
JCJunyi Chen
Junyi Chen
NSNicholas Strieder
Nicholas Strieder
NKNadia G. Krohn
Nadia G. Krohn
PCPhilipp Cyprys
Philipp Cyprys
SSStefanie Sprunck
Stefanie Sprunck
Thomas DresselhausThomas Dresselhaus
Thomas Dresselhaus
Transcription profiles generated from maize gametes and zygotes at different stages reveal a highly dynamic zygotic genome activation pattern, providing insight

1 September 2009 in The Plant Cell
Verified
Journal Article
Closed access
CLChil-Woo Lee
Chil-Woo Lee
MEMarina Efetova
Marina Efetova
JEJulia Engelmann
Julia Engelmann
RKRobert Kramell
Robert Kramell
CWClaus Wasternack
Claus Wasternack
RDRosalia Deeken
Rosalia Deeken
Agrobacterium tumefaciens causes crown gall disease by transferring and integrating bacterial DNA (T-DNA) into the plant genome. To examine the physiological changes and adaptations during Agrobacterium-induced tumor development, we compared the profiles of salicylic acid (SA), ethylene (ET), jasmonic acid (JA), and auxin (indole-3-acetic acid [IAA]) with changes in the Arabidopsis thaliana transcriptome. Our data indicate that host responses were much stronger toward the oncogenic strain C58 than to the disarmed strain GV3101 and that auxin acts as a key modulator of the Arabidopsis–Agrobacterium interaction. At initiation of infection, elevated levels of IAA and ET were associated with the induction of host genes involved in IAA, but not ET signaling. After T-DNA integration, SA as well as IAA and ET accumulated, but JA did not. This did not correlate with SA-controlled pathogenesis-related gene expression in the host, although high SA levels in mutant plants prevented tumor development, while low levels promoted it. Our data are consistent with a scenario in which ET and later on SA control virulence of agrobacteria, whereas ET and auxin stimulate neovascularization during tumor formation. We suggest that crosstalk among IAA, ET, and SA balances pathogen defense launched by the host and tumor growth initiated by agrobacteria.

1 November 2012 in Blood
Verified
Journal Article
Closed access
PDF file
ADAnna Dolnik
Anna Dolnik
JEJulia Engelmann
Julia Engelmann
MSMaren Scharfenberger-Schmeer
Maren Scharfenberger-Schmeer
JMJulian Mauch
Julian Mauch
SKSabine Kelkenberg-Schade
Sabine Kelkenberg-Schade
LBLars Bullinger
Lars Bullinger
Acute myeloid leukemia (AML) is characterized by molecular heterogeneity. As commonly altered genomic regions point to candidate genes involved in leukemogenesis, we used microarray-based comparative genomic hybridization and single nucleotide polymorphism profiling data of 391 AML cases to further narrow down genomic regions of interest. Targeted resequencing of 1000 genes located in the critical regions was performed in a representative cohort of 50 AML samples comprising all major cytogenetic subgroups. We identified 120 missense/nonsense mutations as well as 60 insertions/deletions affecting 73 different genes (∼ 3.6 tumor-specific aberrations/AML). While most of the newly identified alterations were nonrecurrent, we observed an enrichment of mutations affecting genes involved in epigenetic regulation including known candidates like TET2, TET1, DNMT3A, and DNMT1, as well as mutations in the histone methyltransferases NSD1, EZH2, and MLL3. Furthermore, we found mutations in the splicing factor SFPQ and in the nonclassic regulators of mRNA processing CTCF and RAD21. These splicing-related mutations affected 10% of AML patients in a mutually exclusive manner. In conclusion, we could identify a large number of alterations in genes involved in aberrant splicing and epigenetic regulation in genomic regions commonly altered in AML, highlighting their important role in the molecular pathogenesis of AML.

1 December 2006 in The Plant Cell
Verified
Journal Article
Closed access
RDRosalia Deeken
Rosalia Deeken
JEJulia Engelmann
Julia Engelmann
MEMarina Efetova
Marina Efetova
TCTina Czirjak
Tina Czirjak
TMTobias Müller
Tobias Müller
RHRainer Hedrich
Rainer Hedrich
Transformation of plant cells with T-DNA of virulent agrobacteria is one of the most extreme triggers of developmental changes in higher plants. For rapid growth and development of resulting tumors, specific changes in the gene expression profile and metabolic adaptations are required. Increased transport and metabolic fluxes are critical preconditions for growth and tumor development. A functional genomics approach, using the Affymetrix whole genome microarray (∼22,800 genes), was applied to measure changes in gene expression. The solute pattern of Arabidopsis thaliana tumors and uninfected plant tissues was compared with the respective gene expression profile. Increased levels of anions, sugars, and amino acids were correlated with changes in the gene expression of specific enzymes and solute transporters. The expression profile of genes pivotal for energy metabolism, such as those involved in photosynthesis, mitochondrial electron transport, and fermentation, suggested that tumors produce C and N compounds heterotrophically and gain energy mainly anaerobically. Thus, understanding of gene-to-metabolite networks in plant tumors promotes the identification of mechanisms that control tumor development.